%20LIMITED%2029-Jan-2007_files/image002.jpg)
MIRA INFORM REPORT
|
Report Date : |
29th
January, 2007 |
IDENTIFICATION
DETAILS
|
Name : |
SAMI PHARMACEUTICALS (PRIVATE) LIMITED |
|
|
|
|
Registered Office : |
34-C,
Block-6, P.E.C.H.S., Karachi, Pakistan. |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1971 |
|
|
|
|
Com. Reg. No.: |
3227/19710907 |
|
|
|
|
Legal Form : |
Private
Limited Company |
|
|
|
|
Line of Business : |
Manufacture
& Marketing of Pharmaceutical Products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Business Name
SAMI PHARMACEUTICALS (PRIVATE) LIMITED
Full Address
|
Registered Address |
|
34-C,
Block-6, P.E.C.H.S., Karachi, Pakistan. |
|
Tel |
92
(21) 4527490, 4527491, 4527492 |
|
Fax |
92
(21) 4549190, 4549190 |
|
Email |
Short Description Of Business
|
a. |
Nature
of Business |
Manufacture & Marketing of
Pharmaceutical Products |
|
b. |
Year
Established |
1971 |
|
c. |
Registration
# |
3227/19710907 |
Factory Location
|
Address |
F-95,
Off. Hub River Road, S.I.T.E., Karachi-75730, Pakistan. |
|
Tel # |
92
(21) 2578081, 2578082, 2578083 |
|
Fax # |
92
(21) 2563934 |
Auditors
Mohammad
Farooq & Co
(Chartered
Accountants)
Legal Status
Subject Company was established as a Private
Limited Company in 1971
Authorised Capital
Rs. 2,000,000/- divided into 20,000 shares
of Rs. 100/- each
Issued & Paid up Capital
Rs. 1,671,100/- divided into 16,711 shares
of Rs. 100/- each
Details of Directors
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr.
Shamim Ahmed Mr.
Hafiz Ferozuddin Mr.
Abdul Salam |
Pakistani Pakistani Pakistani |
X-37, Block-6, P.E.C.H.S., Karachi 29, Al Hamra Co-operative Housing Society,
Shaheed-e-Millat Road, Karachi 373, Block-3, B.Y.J.C.H.S., Karachi |
Business Business Business |
Chief Executive Director Director |
Shareholders
|
Names |
No. of Shares |
|
Mr.
Hafiz Ferozuddin Mrs
Rehana Khatoon Mr.
Amir Hafiz
M. Umair Hafiz
M. Saad Mrs.
Farhana Mr.
Shamim Ahmed Mr.
Junaid Mr.
Ovais Mr.
Zubair Mr.
Shoaib Mr.
Abdul Salam Mrs.
Humaira Mrs.
Imrana Mrs.
Ayesha Feroz |
257 1,050 3,376 387 520 1,523 83 1,528 3,389 1,407 1,200 269 719 503 500 |
Associates
A. Subsidiary
None
B. Associated
Companies
- Do -
Products
Ammoidin, Antial, Buepron, Caricef, Chymotrip, Conspic, Dicloran, Diclorep, Disgren, Euphen, Flavin, Klint, Klinz, Lospan Plus, Movax, Moxypen, Neucef, Novidat, Oxidil, Pace, Pencit, Penorit, Peridone, Provas, Pulsate, Samerol, Santovir, Sedil, Teph 20, Trimetabol, Uhasil, Ulcerax, Zolen
Number of Employees
146 - 160
Actual Capacity & Production
The
capacity and production of the Company’s plant is indeterminable as it is multi-product and
involves varying processes of manufacture.
Annual Sales Volume
Year In
Pak Rupees
2005 150,000,000/- (Estimated)
Distributors
Mainly in all important cities of
Pakistan
Bankers and their addresses
(1) Askari Commercial Bank Limited,
Shahrah-e-Faisal Branch, Karachi, Pakistan.
(2) Habib
Metropolitan Bank Limited, Hirani Centre, I.I. Chundrigar Road, Karachi,
Pakistan.
(3) Al-Baraka Islamic Bank, Lakhani Centre,
I.I. Chundrigar Road, Karachi, Pakistan.
Financial Position
Sound
Memberships
Pakistan
Pharmaceutical Manufacturers Association.(PPMA)
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US
Dollar |
1 |
Rs.
60.87 |
|
UK
Pound |
1 |
Rs.
119.10 |
|
Euro |
1 |
Rs.
78.50 |
Comments
Subject is a well-established
company having fine track. Directors are reported as experienced, respectable
and having satisfactory means of their own. Their trade relations are reported
as fair. Payments are usually correct and as per commitments. The Company can
be considered for normal business dealings at usual trade terms and conditions.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|